Rahul Kakkar, Chief Executive Officer at Pandion Therapeutics, Inc. (PAND), bought 35,133 shares at $18.00 ($252K) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 21,133 | $0 | 0.0% |
| 2 | $18.00 | 14,000 | $252K | 100.0% |
| Total | $7.17 avg | 35,133 | $252K | 100% |